Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07776821) titled 'An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

Condition: Uterine Cervical Neoplasms

Intervention: Drug: Enlonstobart combined with chemotherapy for induction therapy followed by concurr...